Xiamen Amoytop Biotech Co., Ltd. (SHA:688278)
China
· Delayed Price · Currency is CNY 69.45
-0.68 (-0.97%)
Mar 10, 2026, 1:05 PM CST
Xiamen Amoytop Biotech Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Cash & Equivalents | - | 371.82 | 412.96 | 301.24 | 285.42 | Upgrade
|
| Trading Asset Securities | - | 289.96 | 257.08 | 270.78 | 196.38 | Upgrade
|
| Cash & Short-Term Investments | 825.52 | 661.79 | 670.04 | 572.02 | 481.8 | Upgrade
|
| Cash Growth | 24.74% | -1.23% | 17.14% | 18.73% | 3.53% | Upgrade
|
| Accounts Receivable | - | 808.52 | 441.02 | 223.05 | 206.28 | Upgrade
|
| Other Receivables | - | 22.34 | 17.87 | 20.17 | 21.67 | Upgrade
|
| Receivables | - | 830.86 | 458.9 | 243.22 | 227.94 | Upgrade
|
| Inventory | - | 263.55 | 187.02 | 129.73 | 116.49 | Upgrade
|
| Other Current Assets | - | 70.9 | 24.24 | 10.64 | 8.19 | Upgrade
|
| Total Current Assets | - | 1,827 | 1,340 | 955.61 | 834.42 | Upgrade
|
| Property, Plant & Equipment | - | 686.76 | 490.85 | 389.77 | 192.92 | Upgrade
|
| Other Intangible Assets | - | 170.85 | 191.54 | 121.69 | 146.91 | Upgrade
|
| Long-Term Deferred Tax Assets | - | 69.09 | 43.66 | 47.18 | 34.96 | Upgrade
|
| Long-Term Deferred Charges | - | 221.2 | 176.7 | 229.25 | 169.14 | Upgrade
|
| Other Long-Term Assets | - | 75.35 | 112.98 | 26.05 | 44.99 | Upgrade
|
| Total Assets | - | 3,050 | 2,356 | 1,770 | 1,424 | Upgrade
|
| Accounts Payable | - | 57.76 | 39.73 | 50.91 | 8.14 | Upgrade
|
| Accrued Expenses | - | 233.75 | 244.46 | 159.55 | 120.4 | Upgrade
|
| Short-Term Debt | - | - | - | - | 10 | Upgrade
|
| Current Portion of Leases | - | 5.67 | 4.16 | 4.18 | 5.79 | Upgrade
|
| Current Income Taxes Payable | - | 50.27 | 48.95 | 41.97 | 24.42 | Upgrade
|
| Current Unearned Revenue | - | 63.13 | 60.05 | 7.23 | 5.18 | Upgrade
|
| Other Current Liabilities | - | 10.06 | 6.31 | 4.05 | 3.3 | Upgrade
|
| Total Current Liabilities | - | 420.63 | 403.66 | 267.89 | 177.23 | Upgrade
|
| Long-Term Leases | - | 3.27 | 3.76 | 5.56 | 9.37 | Upgrade
|
| Long-Term Unearned Revenue | - | 32.96 | 40.62 | 47.68 | 51.25 | Upgrade
|
| Long-Term Deferred Tax Liabilities | - | 0.93 | 0.41 | 15.15 | 5.54 | Upgrade
|
| Other Long-Term Liabilities | - | 39.31 | 31.25 | 25.99 | 19.53 | Upgrade
|
| Total Liabilities | - | 497.1 | 479.69 | 362.27 | 262.91 | Upgrade
|
| Common Stock | - | 406.8 | 406.8 | 406.8 | 406.8 | Upgrade
|
| Additional Paid-In Capital | - | 413.14 | 397.04 | 397.04 | 397.04 | Upgrade
|
| Retained Earnings | - | 1,733 | 1,073 | 603.76 | 357.42 | Upgrade
|
| Shareholders' Equity | 3,009 | 2,553 | 1,876 | 1,408 | 1,161 | Upgrade
|
| Total Liabilities & Equity | - | 3,050 | 2,356 | 1,770 | 1,424 | Upgrade
|
| Total Debt | 141.05 | 8.94 | 7.92 | 9.74 | 25.16 | Upgrade
|
| Net Cash (Debt) | 684.47 | 652.85 | 662.11 | 562.28 | 456.63 | Upgrade
|
| Net Cash Growth | 4.84% | -1.40% | 17.76% | 23.14% | 2.28% | Upgrade
|
| Net Cash Per Share | 1.68 | 1.60 | 1.63 | 1.39 | 1.13 | Upgrade
|
| Filing Date Shares Outstanding | 408.19 | 406.8 | 406.8 | 406.8 | 406.8 | Upgrade
|
| Total Common Shares Outstanding | 408.19 | 406.8 | 406.8 | 406.8 | 406.8 | Upgrade
|
| Working Capital | - | 1,406 | 936.53 | 687.72 | 657.19 | Upgrade
|
| Book Value Per Share | 7.40 | 6.28 | 4.61 | 3.46 | 2.85 | Upgrade
|
| Tangible Book Value | 2,566 | 2,382 | 1,685 | 1,286 | 1,014 | Upgrade
|
| Tangible Book Value Per Share | 6.31 | 5.86 | 4.14 | 3.16 | 2.49 | Upgrade
|
| Buildings | - | 291.61 | 135.53 | 118.65 | 21.31 | Upgrade
|
| Machinery | - | 392.63 | 319.97 | 271.83 | 177.83 | Upgrade
|
| Construction In Progress | - | 181.56 | 183.72 | 135.81 | 118 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.